Darren Benjamin Orbach, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vein of Galen Malformations | 11 | 2023 | 53 | 5.030 |
Why?
|
| Embolization, Therapeutic | 22 | 2023 | 1392 | 4.480 |
Why?
|
| Intracranial Arteriovenous Malformations | 11 | 2020 | 356 | 2.560 |
Why?
|
| Arteriovenous Fistula | 7 | 2017 | 315 | 2.440 |
Why?
|
| Cerebral Angiography | 14 | 2023 | 1285 | 2.290 |
Why?
|
| Vascular Malformations | 6 | 2023 | 454 | 2.070 |
Why?
|
| Central Nervous System Vascular Malformations | 6 | 2017 | 145 | 2.050 |
Why?
|
| Cranial Sinuses | 3 | 2017 | 66 | 1.430 |
Why?
|
| Arteriovenous Malformations | 8 | 2014 | 396 | 1.430 |
Why?
|
| Moyamoya Disease | 6 | 2023 | 238 | 1.010 |
Why?
|
| Polyvinyls | 5 | 2014 | 157 | 0.980 |
Why?
|
| Cerebral Veins | 2 | 2023 | 156 | 0.910 |
Why?
|
| Sinus Pericranii | 2 | 2020 | 4 | 0.870 |
Why?
|
| Thrombectomy | 3 | 2022 | 680 | 0.820 |
Why?
|
| Dimethyl Sulfoxide | 3 | 2011 | 249 | 0.780 |
Why?
|
| Cerebrovascular Disorders | 4 | 2020 | 1504 | 0.770 |
Why?
|
| Hydrocephalus | 4 | 2023 | 748 | 0.760 |
Why?
|
| Intracranial Aneurysm | 3 | 2018 | 1197 | 0.750 |
Why?
|
| Retinal Neoplasms | 4 | 2015 | 144 | 0.740 |
Why?
|
| Tantalum | 2 | 2011 | 56 | 0.740 |
Why?
|
| Brain Ischemia | 5 | 2023 | 3265 | 0.730 |
Why?
|
| Endovascular Procedures | 8 | 2022 | 1979 | 0.730 |
Why?
|
| Retinoblastoma | 4 | 2015 | 318 | 0.700 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2017 | 1695 | 0.690 |
Why?
|
| Cerebral Revascularization | 4 | 2023 | 238 | 0.690 |
Why?
|
| Radiology, Interventional | 3 | 2023 | 460 | 0.680 |
Why?
|
| Basilar Artery | 2 | 2017 | 200 | 0.680 |
Why?
|
| Sclerotherapy | 3 | 2019 | 175 | 0.660 |
Why?
|
| Magnetic Resonance Imaging | 22 | 2023 | 35421 | 0.640 |
Why?
|
| Neurocutaneous Syndromes | 3 | 2019 | 51 | 0.620 |
Why?
|
| Vascular Diseases | 2 | 2023 | 1161 | 0.610 |
Why?
|
| Ventriculostomy | 1 | 2019 | 136 | 0.600 |
Why?
|
| Magnetic Resonance Angiography | 6 | 2023 | 1442 | 0.590 |
Why?
|
| Myxoma | 1 | 2018 | 130 | 0.580 |
Why?
|
| Vertebral Artery | 2 | 2015 | 192 | 0.570 |
Why?
|
| Intracranial Hypertension | 1 | 2019 | 186 | 0.560 |
Why?
|
| Radiation Dosage | 2 | 2015 | 1928 | 0.550 |
Why?
|
| Child | 48 | 2023 | 77709 | 0.540 |
Why?
|
| Stroke | 9 | 2023 | 9981 | 0.540 |
Why?
|
| Hyperthermia, Induced | 2 | 2009 | 403 | 0.530 |
Why?
|
| Hemangioma | 3 | 2013 | 738 | 0.530 |
Why?
|
| Melphalan | 2 | 2014 | 431 | 0.530 |
Why?
|
| Pia Mater | 3 | 2012 | 88 | 0.510 |
Why?
|
| Echoencephalography | 1 | 2015 | 135 | 0.510 |
Why?
|
| Blue Toe Syndrome | 1 | 2014 | 4 | 0.500 |
Why?
|
| Disease Management | 2 | 2017 | 2459 | 0.500 |
Why?
|
| Head | 3 | 2021 | 880 | 0.490 |
Why?
|
| Child, Preschool | 28 | 2023 | 41006 | 0.480 |
Why?
|
| Infant | 29 | 2023 | 35136 | 0.480 |
Why?
|
| Epidural Space | 1 | 2015 | 124 | 0.480 |
Why?
|
| Spinal Cord | 3 | 2011 | 1809 | 0.460 |
Why?
|
| Bradycardia | 2 | 2015 | 307 | 0.450 |
Why?
|
| Electroencephalography | 6 | 2017 | 6150 | 0.450 |
Why?
|
| Head Movements | 2 | 2011 | 150 | 0.450 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2014 | 627 | 0.440 |
Why?
|
| Infant, Newborn | 17 | 2023 | 25625 | 0.430 |
Why?
|
| Neck | 2 | 2021 | 697 | 0.420 |
Why?
|
| Radiography, Interventional | 3 | 2015 | 1095 | 0.420 |
Why?
|
| p120 GTPase Activating Protein | 2 | 2023 | 39 | 0.420 |
Why?
|
| Stents | 3 | 2016 | 3280 | 0.420 |
Why?
|
| Brain Stem | 1 | 2017 | 846 | 0.400 |
Why?
|
| Myofibromatosis | 1 | 2011 | 30 | 0.400 |
Why?
|
| Sinus Thrombosis, Intracranial | 2 | 2023 | 103 | 0.390 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2009 | 1018 | 0.380 |
Why?
|
| Angiofibroma | 1 | 2011 | 68 | 0.370 |
Why?
|
| Catheterization, Peripheral | 1 | 2014 | 345 | 0.370 |
Why?
|
| Echo-Planar Imaging | 2 | 2013 | 659 | 0.370 |
Why?
|
| Epilepsies, Partial | 3 | 2010 | 436 | 0.360 |
Why?
|
| Eye Abnormalities | 3 | 2019 | 246 | 0.350 |
Why?
|
| Angiography | 4 | 2021 | 1639 | 0.350 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2013 | 547 | 0.350 |
Why?
|
| Humans | 92 | 2023 | 744343 | 0.340 |
Why?
|
| Fluoroscopy | 1 | 2013 | 924 | 0.340 |
Why?
|
| Reflex | 1 | 2011 | 365 | 0.340 |
Why?
|
| Hospitals, Pediatric | 2 | 2017 | 1775 | 0.340 |
Why?
|
| Catheterization | 4 | 2022 | 1470 | 0.330 |
Why?
|
| Neovascularization, Pathologic | 2 | 2009 | 2635 | 0.330 |
Why?
|
| Hemostatics | 1 | 2011 | 229 | 0.320 |
Why?
|
| Epidural Neoplasms | 1 | 2008 | 24 | 0.320 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2011 | 286 | 0.320 |
Why?
|
| Thrombosis | 1 | 2022 | 2968 | 0.320 |
Why?
|
| Vertebral Artery Dissection | 1 | 2008 | 48 | 0.310 |
Why?
|
| Spine | 2 | 2015 | 1144 | 0.310 |
Why?
|
| Radiography | 7 | 2015 | 7023 | 0.300 |
Why?
|
| Foreign Bodies | 1 | 2011 | 399 | 0.290 |
Why?
|
| Genes, Dominant | 1 | 2009 | 880 | 0.290 |
Why?
|
| Male | 51 | 2023 | 350118 | 0.280 |
Why?
|
| Skull Base | 1 | 2009 | 306 | 0.270 |
Why?
|
| Image Enhancement | 4 | 2015 | 2921 | 0.260 |
Why?
|
| Aortic Coarctation | 2 | 2019 | 281 | 0.260 |
Why?
|
| Brain | 5 | 2023 | 26385 | 0.260 |
Why?
|
| Female | 48 | 2023 | 380194 | 0.260 |
Why?
|
| Retrospective Studies | 27 | 2023 | 77449 | 0.250 |
Why?
|
| Cerebral Hemorrhage | 2 | 2015 | 2647 | 0.240 |
Why?
|
| Papilloma, Choroid Plexus | 1 | 2023 | 9 | 0.240 |
Why?
|
| Choroid Plexus Neoplasms | 1 | 2023 | 43 | 0.230 |
Why?
|
| Microsurgery | 3 | 2015 | 796 | 0.230 |
Why?
|
| Abnormalities, Multiple | 1 | 2011 | 1416 | 0.230 |
Why?
|
| Mastoiditis | 1 | 2023 | 34 | 0.220 |
Why?
|
| Receptor, EphB4 | 2 | 2020 | 38 | 0.220 |
Why?
|
| Thrombolytic Therapy | 1 | 2012 | 2161 | 0.220 |
Why?
|
| Chromosome Aberrations | 1 | 2009 | 1813 | 0.220 |
Why?
|
| Adolescent | 22 | 2021 | 85781 | 0.220 |
Why?
|
| Parotid Neoplasms | 1 | 2004 | 155 | 0.220 |
Why?
|
| Vascular Neoplasms | 1 | 2004 | 175 | 0.210 |
Why?
|
| Artifacts | 1 | 2011 | 1904 | 0.210 |
Why?
|
| Brain Neoplasms | 3 | 2015 | 8863 | 0.210 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2013 | 3327 | 0.210 |
Why?
|
| Umbilical Arteries | 1 | 2022 | 75 | 0.210 |
Why?
|
| Punctures | 1 | 2023 | 374 | 0.210 |
Why?
|
| Preoperative Care | 1 | 2011 | 2250 | 0.210 |
Why?
|
| Meningeal Neoplasms | 2 | 2021 | 1241 | 0.210 |
Why?
|
| Spinal Neoplasms | 1 | 2009 | 760 | 0.200 |
Why?
|
| Head and Neck Neoplasms | 2 | 2017 | 2734 | 0.200 |
Why?
|
| Ethics Committees, Research | 1 | 2023 | 194 | 0.200 |
Why?
|
| Muscle Weakness | 1 | 2004 | 413 | 0.190 |
Why?
|
| Superior Sagittal Sinus | 1 | 2020 | 17 | 0.190 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 4186 | 0.190 |
Why?
|
| Otitis Media | 1 | 2023 | 277 | 0.190 |
Why?
|
| Phantoms, Imaging | 3 | 2017 | 2480 | 0.190 |
Why?
|
| Foot | 1 | 2004 | 527 | 0.190 |
Why?
|
| Ephrin-B2 | 1 | 2020 | 39 | 0.180 |
Why?
|
| Follow-Up Studies | 11 | 2023 | 39050 | 0.180 |
Why?
|
| Granuloma, Pyogenic | 1 | 2020 | 48 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 3 | 2016 | 7279 | 0.180 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 1107 | 0.180 |
Why?
|
| Veins | 3 | 2023 | 770 | 0.180 |
Why?
|
| Somatoform Disorders | 1 | 2003 | 423 | 0.170 |
Why?
|
| Conversion Disorder | 1 | 2003 | 205 | 0.170 |
Why?
|
| Heart Failure | 1 | 2023 | 10900 | 0.170 |
Why?
|
| Infusions, Intra-Arterial | 2 | 2021 | 234 | 0.170 |
Why?
|
| Catheters | 1 | 2022 | 425 | 0.170 |
Why?
|
| Bone Cysts, Aneurysmal | 1 | 2019 | 73 | 0.160 |
Why?
|
| Carotid Stenosis | 1 | 2006 | 854 | 0.160 |
Why?
|
| Third Ventricle | 1 | 2019 | 76 | 0.160 |
Why?
|
| Rhabdomyosarcoma | 1 | 2021 | 382 | 0.150 |
Why?
|
| Video Recording | 1 | 2003 | 949 | 0.150 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2013 | 604 | 0.150 |
Why?
|
| Epilepsy | 2 | 2011 | 3310 | 0.150 |
Why?
|
| Treatment Outcome | 13 | 2023 | 63114 | 0.150 |
Why?
|
| Glomus Tumor | 1 | 2017 | 66 | 0.140 |
Why?
|
| Pregnancy | 4 | 2023 | 29144 | 0.140 |
Why?
|
| Polysomnography | 1 | 2003 | 1776 | 0.140 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2006 | 3760 | 0.140 |
Why?
|
| Checklist | 1 | 2023 | 833 | 0.130 |
Why?
|
| Pons | 1 | 2017 | 245 | 0.130 |
Why?
|
| Cerebellum | 2 | 2016 | 1488 | 0.130 |
Why?
|
| Radio Waves | 1 | 2017 | 251 | 0.130 |
Why?
|
| Varicose Veins | 1 | 2017 | 154 | 0.130 |
Why?
|
| Neoplasm Seeding | 1 | 2015 | 87 | 0.130 |
Why?
|
| Ultrasonography, Interventional | 1 | 2023 | 1486 | 0.130 |
Why?
|
| Age Factors | 4 | 2013 | 18370 | 0.130 |
Why?
|
| Fetus | 1 | 2022 | 1880 | 0.120 |
Why?
|
| Brain Damage, Chronic | 1 | 2015 | 265 | 0.120 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 3507 | 0.120 |
Why?
|
| Electrodes | 1 | 2017 | 619 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2018 | 635 | 0.120 |
Why?
|
| Spinal Diseases | 1 | 2019 | 538 | 0.120 |
Why?
|
| Ions | 1 | 2014 | 265 | 0.120 |
Why?
|
| Intracranial Embolism | 1 | 2015 | 202 | 0.120 |
Why?
|
| Hydrodynamics | 1 | 2014 | 158 | 0.110 |
Why?
|
| Brain Mapping | 3 | 2016 | 6669 | 0.110 |
Why?
|
| Materials Testing | 1 | 2017 | 867 | 0.110 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2023 | 341 | 0.110 |
Why?
|
| Meningioma | 1 | 2021 | 1209 | 0.110 |
Why?
|
| Equipment Failure | 1 | 2015 | 578 | 0.110 |
Why?
|
| Cohort Studies | 7 | 2021 | 40561 | 0.110 |
Why?
|
| Intracranial Hemorrhages | 1 | 2018 | 855 | 0.110 |
Why?
|
| Oral Hemorrhage | 1 | 2011 | 27 | 0.100 |
Why?
|
| Balloon Occlusion | 1 | 2013 | 126 | 0.100 |
Why?
|
| Mouth Abnormalities | 1 | 2011 | 19 | 0.100 |
Why?
|
| Hypertension, Pulmonary | 1 | 2023 | 1537 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2022 | 5078 | 0.100 |
Why?
|
| Young Adult | 9 | 2020 | 56430 | 0.100 |
Why?
|
| Registries | 2 | 2021 | 8089 | 0.100 |
Why?
|
| Radiology | 1 | 2006 | 2100 | 0.100 |
Why?
|
| Lymphangioma, Cystic | 1 | 2011 | 34 | 0.100 |
Why?
|
| Skin Diseases | 1 | 2020 | 1065 | 0.100 |
Why?
|
| Brain Waves | 1 | 2016 | 401 | 0.100 |
Why?
|
| Cerebrospinal Fluid | 1 | 2014 | 534 | 0.100 |
Why?
|
| Endothelial Cells | 2 | 2023 | 3479 | 0.100 |
Why?
|
| Fibrinolytic Agents | 1 | 2021 | 2158 | 0.100 |
Why?
|
| Brain Injuries | 1 | 2023 | 2025 | 0.100 |
Why?
|
| Hot Temperature | 1 | 2017 | 1354 | 0.090 |
Why?
|
| Prognosis | 4 | 2021 | 29063 | 0.090 |
Why?
|
| Progeria | 1 | 2012 | 185 | 0.090 |
Why?
|
| Syndrome | 2 | 2021 | 3251 | 0.090 |
Why?
|
| Activin Receptors, Type II | 2 | 2023 | 127 | 0.090 |
Why?
|
| Lymphatic Abnormalities | 1 | 2011 | 133 | 0.090 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 1 | 2010 | 68 | 0.090 |
Why?
|
| Seizures | 1 | 2003 | 2859 | 0.090 |
Why?
|
| Adult | 16 | 2023 | 214055 | 0.090 |
Why?
|
| Solvents | 1 | 2011 | 302 | 0.090 |
Why?
|
| Ultrasonography | 1 | 2023 | 5985 | 0.090 |
Why?
|
| Evoked Potentials, Motor | 1 | 2013 | 454 | 0.090 |
Why?
|
| Middle Aged | 13 | 2021 | 213383 | 0.090 |
Why?
|
| Hemangioma, Capillary | 1 | 2009 | 61 | 0.090 |
Why?
|
| Trigeminal Nerve | 1 | 2011 | 249 | 0.090 |
Why?
|
| Stomatitis | 1 | 2011 | 269 | 0.080 |
Why?
|
| Femoral Artery | 1 | 2013 | 845 | 0.080 |
Why?
|
| Connective Tissue Diseases | 1 | 2011 | 264 | 0.080 |
Why?
|
| Neurosurgical Procedures | 2 | 2020 | 2002 | 0.080 |
Why?
|
| Spinal Cord Compression | 1 | 2009 | 235 | 0.080 |
Why?
|
| Age Distribution | 1 | 2013 | 2902 | 0.080 |
Why?
|
| Boston | 2 | 2017 | 9313 | 0.070 |
Why?
|
| Retreatment | 1 | 2009 | 610 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 7913 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 6364 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2013 | 14722 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2010 | 8949 | 0.070 |
Why?
|
| Neurologic Examination | 1 | 2009 | 930 | 0.070 |
Why?
|
| Incidence | 3 | 2020 | 20947 | 0.070 |
Why?
|
| Device Removal | 1 | 2011 | 656 | 0.070 |
Why?
|
| Vascular Surgical Procedures | 1 | 2015 | 1475 | 0.070 |
Why?
|
| Movement | 1 | 2013 | 1471 | 0.070 |
Why?
|
| Drug Combinations | 1 | 2011 | 1959 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2014 | 20129 | 0.060 |
Why?
|
| Motor Cortex | 1 | 2013 | 986 | 0.060 |
Why?
|
| Reproducibility of Results | 4 | 2013 | 19905 | 0.060 |
Why?
|
| Radiosurgery | 1 | 2015 | 1329 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 12959 | 0.060 |
Why?
|
| Lumbar Vertebrae | 2 | 2019 | 1848 | 0.060 |
Why?
|
| Positron-Emission Tomography | 1 | 2021 | 6234 | 0.060 |
Why?
|
| Mutation | 5 | 2023 | 29786 | 0.060 |
Why?
|
| Pediatrics | 1 | 2019 | 3475 | 0.060 |
Why?
|
| Lethargy | 1 | 2023 | 39 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2012 | 1456 | 0.060 |
Why?
|
| Thoracic Vertebrae | 1 | 2008 | 608 | 0.060 |
Why?
|
| Hemorrhage | 1 | 2015 | 3461 | 0.060 |
Why?
|
| Linear Models | 1 | 2013 | 5952 | 0.060 |
Why?
|
| Angioplasty | 1 | 2006 | 364 | 0.060 |
Why?
|
| Oxygen | 1 | 2014 | 4189 | 0.050 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2023 | 2737 | 0.050 |
Why?
|
| Alpha Rhythm | 1 | 2003 | 120 | 0.050 |
Why?
|
| Skin Neoplasms | 2 | 2013 | 5686 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2015 | 8642 | 0.050 |
Why?
|
| Cervical Vertebrae | 1 | 2008 | 975 | 0.050 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2005 | 403 | 0.050 |
Why?
|
| Statistics as Topic | 1 | 2008 | 2373 | 0.050 |
Why?
|
| Algorithms | 2 | 2013 | 13881 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2013 | 3589 | 0.050 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2020 | 29 | 0.050 |
Why?
|
| Mass Screening | 1 | 2016 | 5255 | 0.050 |
Why?
|
| GTPase-Activating Proteins | 1 | 2023 | 498 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11524 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8388 | 0.040 |
Why?
|
| Blood Loss, Surgical | 1 | 2023 | 662 | 0.040 |
Why?
|
| Ephrins | 1 | 2018 | 27 | 0.040 |
Why?
|
| Cerebral Infarction | 1 | 2023 | 1011 | 0.040 |
Why?
|
| Corpus Callosum | 1 | 2003 | 737 | 0.040 |
Why?
|
| Postoperative Complications | 4 | 2023 | 15295 | 0.040 |
Why?
|
| Catheter Ablation | 1 | 2011 | 2758 | 0.040 |
Why?
|
| Aged | 4 | 2016 | 163280 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2016 | 23338 | 0.040 |
Why?
|
| Doxycycline | 1 | 2019 | 326 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2021 | 890 | 0.040 |
Why?
|
| Metalloendopeptidases | 1 | 2018 | 396 | 0.040 |
Why?
|
| Penetrance | 1 | 2018 | 381 | 0.040 |
Why?
|
| Arousal | 1 | 2003 | 1165 | 0.040 |
Why?
|
| Hematoma | 1 | 2021 | 758 | 0.040 |
Why?
|
| Cerebral Arteries | 1 | 2019 | 494 | 0.030 |
Why?
|
| Turtles | 1 | 2016 | 40 | 0.030 |
Why?
|
| Neuropsychological Tests | 2 | 2005 | 6993 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2021 | 1602 | 0.030 |
Why?
|
| Genotype | 1 | 2009 | 12951 | 0.030 |
Why?
|
| Genes, ras | 1 | 2018 | 690 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2021 | 2242 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2010 | 21746 | 0.030 |
Why?
|
| United States | 1 | 2023 | 69872 | 0.030 |
Why?
|
| Genes, Retinoblastoma | 1 | 2015 | 136 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 15076 | 0.030 |
Why?
|
| Age of Onset | 1 | 2021 | 3271 | 0.030 |
Why?
|
| Ophthalmic Artery | 1 | 2014 | 60 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2023 | 2564 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2023 | 2132 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2016 | 315 | 0.030 |
Why?
|
| Injections, Intra-Arterial | 1 | 2013 | 193 | 0.030 |
Why?
|
| Sirolimus | 1 | 2021 | 1564 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 2012 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 7181 | 0.030 |
Why?
|
| Dominance, Cerebral | 2 | 2005 | 635 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2023 | 2305 | 0.030 |
Why?
|
| Animals | 4 | 2023 | 168757 | 0.030 |
Why?
|
| Headache | 1 | 2020 | 1226 | 0.030 |
Why?
|
| ROC Curve | 1 | 2020 | 3527 | 0.030 |
Why?
|
| Joint Instability | 1 | 2019 | 792 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 13695 | 0.020 |
Why?
|
| Pedigree | 1 | 2018 | 4644 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2016 | 1767 | 0.020 |
Why?
|
| Recurrence | 1 | 2021 | 8340 | 0.020 |
Why?
|
| Eye | 1 | 2013 | 729 | 0.020 |
Why?
|
| Risk Factors | 2 | 2013 | 72290 | 0.020 |
Why?
|
| Forecasting | 1 | 2018 | 2951 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2016 | 1534 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2023 | 23403 | 0.020 |
Why?
|
| Migraine Disorders | 1 | 2020 | 1620 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2023 | 4599 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2021 | 6196 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 15540 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2018 | 3768 | 0.020 |
Why?
|
| Consensus | 1 | 2016 | 2959 | 0.020 |
Why?
|
| Gene Expression | 1 | 2020 | 7799 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2003 | 5708 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2021 | 6544 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2011 | 1530 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2020 | 13033 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2020 | 19229 | 0.010 |
Why?
|
| Pain | 1 | 2019 | 4986 | 0.010 |
Why?
|
| Phenotype | 1 | 2021 | 16365 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 13989 | 0.010 |
Why?
|
| Reoperation | 1 | 2011 | 4201 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2021 | 12208 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 57776 | 0.010 |
Why?
|
| Physicians | 1 | 2019 | 4567 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11031 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 2005 | 1670 | 0.010 |
Why?
|
| Mice | 1 | 2023 | 81183 | 0.010 |
Why?
|
| Comorbidity | 1 | 2010 | 10388 | 0.010 |
Why?
|
| Memory | 1 | 2005 | 2174 | 0.010 |
Why?
|
| Hippocampus | 1 | 2005 | 3675 | 0.010 |
Why?
|